The Vitality Mammography Messaging Study
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 7655
- Registration Number
- NCT06277141
- Locations
- πΏπ¦
University of Witwatersrand, Johannesburg, Gauteng, South Africa
Testing the Effectiveness of Different Messaging Approaches to Increase Doctor Visits Amongst Individuals With Risk Factors for Diabetes
- Conditions
- Interventions
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 5000
- Registration Number
- NCT05755555
- Locations
- πΏπ¦
Discovery Vitality, Johannesburg, Gauteng, South Africa
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
- Conditions
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 500000
- Registration Number
- NCT05148845
- Locations
- πΏπ¦
Josha Research, Bloemfontein, Free State, South Africa
πΏπ¦Emavundleni Research Centre, Cape Town, Western CAPE, South Africa
πΏπ¦TASK Applied Science, Brooklyn Chest Hospital Premises, Cape town, Western Cape, South Africa
Sisonke (Together): OPEN LABEL TRIAL COVID-19
- Conditions
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 477102
- Registration Number
- NCT04838795
- Locations
- πΏπ¦
PHOENIX Pharma Pty Ltd, Port Elizabeth, Eastern Cape, South Africa
πΏπ¦Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern Cape, South Africa
πΏπ¦Perinatal HIV Research Unit Kliptown, Johannesburg, Gauteng - South, South Africa
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 74
- Registration Number
- NCT04581915
- Locations
- πΏπ¦
The Perinatal HIV Research Unit - Matlosana, Klerksdorp, North West Province, South Africa
Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
- Conditions
- Interventions
- First Posted Date
- 2019-08-20
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 402
- Registration Number
- NCT04062201
- Locations
- πΏπ¦
Jose Pearson TB Hospital, Port Elizabeth, Eastern Cape, South Africa
πΏπ¦King DinuZulu Hospital Complex, Durban, KwaZulu Natal, South Africa
The CHAPS Trial: Combined HIV Adolescent PrEP and Prevention
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT03986970
- Locations
- πΏπ¦
The Perinatal HIV Research Unit, Johannesburg, Gauteng, South Africa